Biomedical Engineering Reference
In-Depth Information
[140] Shek PN , Barber RF . Liposomes: a new generation of drug and vaccine carriers . Mod
Med 1986 ; 41 : 314 - 26 .
[141] Onoue S , Yamada S , Yajima T . Bioactive analogues and drug delivery systems of vasoac-
tive intestinal peptide (VIP) for the treatment of asthma/COPD . Peptides 2007 ; 28 : 1640 - 5 0 .
[142] Lu D , Hickey A . Liposomal dry powders as aerosols for pulmonary delivery of proteins .
AAPS Pharm Sci Tech 2005 ; 6 : E641 - 8 .
[143] Shahiwala A , Misra A . A preliminary pharmacokinetic study of liposomal leuprolide
dry powder inhaler: a technical note . AAPS Pharm Sci Tech 2005 ; 6 : E482 - 6 .
[144] Shahiwala A , Misra A . Pulmonary absorption of liposomal levonorgestral . AAPS
Pharm Sci Tech 2004 ; 5 : E13 .
[145] Hui KP , Taylor IK , Taylor GW , Rubin P , Kesterson J , Barnes NC , et al . Effect of a 5-lipoxy-
genase inhibitor on leukotriene challenge in asthmatic patients
1991 ; 46 : 184 - 9 .
[146] Qui Y , Gupta P , Cheskin H , Adjei A . Pulmonary bioavailability and absorption char-
acteristics of the 5-lipoxygenase inhibitor, Abbott-79175, in beagle dogs . Int J Pharm
1995 ; 115 : 95 - 102 .
[147] Stribling R , Brunette E ,
. Thorax
Liggitt D , Gaensler K , Debs R . Aerosol gene delivery in vivo .
Proc Natl Acad Sci USA 1992 ; 89 : 11277 - 81 .
[148] Cefalu WT, Balagtas CC, Landschulz WH, Gelfand RA. Sustained efficacy and pulmo-
nary safety of inhaled insulin during 2 years of outpatient therapy. Poster Presented at
American Diabetes Association 60th Scientific Sessions, San Antonio, Texas, June, for
the Inhaled Insulin Phase II Study Group, Burlington, VT., & Groton, CT; 2000.
[149] Ogden J , Rogerson C , Smith I . Issues in pulmonary delivery . Scrip 1996 ; June : 56 - 60 .
[150] Kohler D . Aerosolized heparin . J Aerosol Med 1994 ; 7 : 307 - 14 .
[151] Kinnula V , Cantell K , Mattson K . Effect of inhaled natural interferon-alpha on diffuse
bronchioalveolar carcinoma . Eur J Cancer 1990 ; 26 : 740 - 1 .
[152] Martin RJ , Boguniewicz M , Henson JE . The effects of inhaled interferon gamma in nor-
mal human airways . Am Rev Respir Dis 1993 ; 148 : 1677 - 82 .
[153] McElvaney NG , Hubbard RC , Birrer P . Aerosol α-1 antitrypsin treatment for cystic
fibrosis . Lancet 1991 ; 337 : 392 - 4 .
[154] Hall
CB .
Aerosolized
treatment
of
acute
pulmonary
infections .
J
Aerosol
Med
1989 ; 2 : 221 - 31 .
[155] Knight V , Yu CP , Gilbert BE , Divine GW . Estimating the dosage of ribavirin aerosol
according to age and other variables . J Infect Dis 1998 ; 158 : 443 - 8 .
[156] Gonda I . Targeting by deposition . In: Hickey AJ , editor. Pharmaceutical inhalation aero-
sol technology . New York, NY : Marcel Dekker ; 1992 . p. 61 - 82 .
[157] Knight V , Waldrep JC . New approaches in aerosol drug delivery for the treatment of
asthma . In: Kay AB , editor. Allergy and allergic diseases . Oxford, England : Blackwell
Scientific Publications ; 1996 . p. 726 - 37 .
[158] Scheuch G , Stahlhofen W . Deposition and dispersion of aerosol in the airways of the
human respiratory tract: the effect of particle size . Exp Lung Res 1992 ; 18 : 343 - 58 .
[159] Rau JL . The inhalation of drugs: advantages and problems . Respir Care 2005 ; 50 : 367 - 82 .
[160] McCallion ONM , Taylor KMG , Bridges PA , Thomas M , Taylor AJ . Jet nebulisers for
pulmonary drug delivery . Int J Pharm 1996 ; 130 : 1 - 11 .
[161] Waldrep JC , Dhand R . Advanced nebulizer designs employing vibrating mesh/aperture
plate technologies for aerosol generation . Curr Drug Deliv 2008 ; 5 : 114 - 19 .
[162] Zainudin BM , Biddiscombe M , Tolfree SE , Short M , Spiro SG
. Comparison of broncho-
dilator responses and deposition patterns of salbutamol inhaled from a pressurised metered
dose inhaler, as a dry powder, and as a nebulised solution . Thorax 1990 ; 45 : 469 - 73 .
[163] Anderson P . Use of Respimat soft mist inhaler in COPD patients . Int J Chronic Obstruct
Pulm Dis 2006 ; 1 : 251 - 9 .
Search WWH ::




Custom Search